Wordt geladen...
ROADMAP and ORIENTAL Trials: the Re-emergence of J-Curve Ghost?
It still remains unknown whether angiotensin-receptor blockers (ARBs) are cardioprotective in patients with type 2 diabetes. The recent two clinical trials, the ROADMAP and the ORIENT, have suggested that fatal cardiovascular events or cardiovascular deaths were unexpectedly higher in olmesartan gro...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Libertas Academica
2011
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3699452/ https://ncbi.nlm.nih.gov/pubmed/23885187 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/JCM.S7521 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|